Ligand validation:3RHL

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RHL_GOL_A_2000	53%	85%	0.134	0.897	0.3	0.44	-	-	0	0	100%	1
3RHL_GOL_C_2002	41%	90%	0.161	0.875	0.27	0.33	-	-	1	0	100%	1
3RHL_GOL_D_2003	30%	80%	0.197	0.861	0.31	0.53	-	-	0	0	100%	1
3RHL_GOL_B_2001	29%	87%	0.217	0.874	0.27	0.43	-	-	0	0	100%	1
3RHM_GOL_A_2001	61%	54%	0.121	0.911	0.57	1.19	-	-	0	0	100%	1
3RHO_GOL_B_3026	48%	70%	0.17	0.912	0.55	0.57	-	-	2	0	100%	1
3RHP_GOL_B_10	36%	43%	0.248	0.941	0.37	1.87	-	1	1	0	100%	1
1SSX_GOL_A_249	100%	72%	0.032	0.994	0.64	0.43	-	-	0	0	100%	0.8
4CJ0_GOL_A_1582	100%	73%	0.037	0.994	0.7	0.35	-	-	0	0	100%	1
7T8M_GOL_A_401	100%	41%	0.039	0.991	1.21	1.14	-	-	0	0	100%	1
4UQL_GOL_Q_1553	100%	89%	0.04	0.991	0.35	0.29	-	-	0	0	100%	1
8A3H_GOL_A_601	100%	92%	0.041	0.989	0.27	0.27	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.